Work

Immune Checkpoint Inhibitors and Mesenchymal Stem/Stromal Cells Combination Therapy Might Offer a Promising Treatment Option for Cancer

Year: 2022

Type: article

Source: Stem Cell Reviews and Reports

DOI: 10.1007/s12015-022-10474-1

Authors: Ahmed Lotfy, Hongjun Wang

Institutions: Medical University of South Carolina, Ralph H. Johnson VA Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G2387291307, G2565907284, G3276194190, G330187846, Novel Gene and Stem Cell Therapy for Type 1 Diabetes, G561734486, G5787602321, G7417865685, G829597878, G8510644658

OpenAlex ID: W4310568396

FWCI: 0.361

Cites: 8

Cited by: 4

Related to: 10